Innovations24

What we do

Industries

Insights

Pharmaceuticals

Global Healthcare Company Improves Operations Through Strategic IT Project Overhaul

Primary Area

Infrastructure & Cloud

Service Area

SharePoint Infrastructure Setup (Virtualization/Networking)

Products Used

SharePoint, Hyper-V

Roles Impacted

Chemical Engineers, other Scientists

Impact Highlight

85 % reduction in approval lead time

Opportunity

Facing stringent FDA 21 CFR Part 11 requirements, a top‑10 global pharmaceutical company relied on couriered paper packets to capture wet‑ink signatures across 37 manufacturing and R&D sites worldwide. The delays, compliance exposures, and lack of audit traceability presented a clear opportunity to digitize approval workflows and elevate data integrity.

Challenges:

  • 5–10 day average turnaround for critical batch records.

  • 12 regional archives storing over 2 million pages, risking loss or tampering.

  • No real‑time visibility for Quality and Regulatory Affairs teams.

  • Manual reconciliation of signer identity.

  • Duplicate effort to meet Part 11 controls (audit trails, timestamps, record–signature linkage).

Solution

Our team formed a cross‑functional steering group, mapped current‑state processes, and introduced a harmonized signature capture model. The team architected and deployed three SharePoint farms with integrated Power Automate, Azure AD, and SharePoint Framework‑based DocuSign components, validated to Part 11 using GxP‑compliant templates.

  • People: Key users trained in electronic‑records SOPs.

  • Process: Electronic‑signature policy updated and approved.

  • Technology:

    • SharePoint with storage for sealed document capture.

    • Azure AD Conditional Access + MFA for unique signer authentication.

    • Power Automate & Power Apps for role‑based approval flows.

    • DocuSign for SharePoint add‑in with cryptographic timestamping.

    • Migrated GMP documents from Documentum and network shares.

Impact

Signature cycle time dropped from an average of 8 days to one day, and first‑pass compliance in FDA mock audits rose to 99 %. The platform now delivers clear traceability while saving a considerable amount in courier, storage, and deviation‑remediation costs.

  • 85 % reduction in approval lead time.

  • Cut in audit‑preparation effort.

  • 25 % decrease in batch‑release deviations linked to documentation errors.

  • Sheets of paper eliminated per year.

  • Scalable architecture aligned to Microsoft 365 cloud‑transition.